Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:3.4.24.35 (
matrix metalloproteinase 9
)
2,207
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
In the present study the aim was to measure the levels of Thrombospondin-1 (TSP1) and Lipocalin-2/
matrix metalloproteinase 9
(
MMP9
/NGAL) complex in gingival crevicular fluid (GCF) at different time points of orthodontic treatment, to determine the relationship between these values and those of total-matrix metalloproteinase 9 (MMP9) and theirs implication in angiogenesis balance, in the situation of a good control of the bacterial plaque, emphasizing the role of TSP1 and
MMP9
/NGAL complex. GCF samples were collected from 16 young orthodontic patients requiring upper canine distalization (test tooth) with first premolar extraction. The contralateral canine (control tooth) was free from orthodontic force. For the orthodontic appliance, brackets
Roth
0.018 inch with 0.012 inch NiTi archwire and a laceback were used. TSP1,
MMP9
/NGAL, and
MMP9
increased from 1 hour before activation of orthodontic appliance to a maximum at 8 hours for
MMP9
and 72 hours for
MMP9
/NGAL and TSP1. The results show a change in time of TSP1,
MMP9
/NGAL, and
MMP9
levels in GCF of patients with this method of orthodontic treatment. The powerful correlation of
MMP9
/NGAL with TSP1 suggests their stronger involvement in angiogenesis processes in PDL during orthodontic periodontal remodeling, in the situation of a healthy periodontium and a good control of the bacterial plaque.
...
PMID:Involvement of TSP1 and MMP9/NGAL in angiogenesis during orthodontic periodontal remodeling. 2496 33